ArticleFuture oncology (London, England)Published
Real-world outcomes with fedratinib therapy in patients who discontinued ruxolitinib for primary myelofibrosis
Regional connection
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
- Institution
- Bristol Myers Squibb
- County
- Mercer County
Publication record
- Type
- Article
- Venue
- Future oncology (London, England)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Sulfonamides; Nitriles; Pyrazoles; Pyrimidines; Pyrrolidines; Protein Kinase Inhibitors; Treatment Outcome; Retrospective Studies; Aged; Aged, 80 and over; Middle Aged
- PubMed ID
- 37991002
- PubMed Central ID
- PMC11318674
- Open access
- Yes, open
- Added to directory
- Source checked